PlumX Metrics
Embed PlumX Metrics

Clinical use of biologics in vasculitis syndromes

Biologics: Targets and Therapy, ISSN: 1177-5475, Vol: 6, Page: 371-378
2012
  • 4
    Citations
  • 0
    Usage
  • 47
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Review Description

Vasculitis syndromes are relative rare conditions but can cause significant mortality and morbidity if not treated adequately. Recent advances in immunosuppressant therapy have radically changed the course of these diseases. However, the standard therapy is not always well tolerated by patients, and some cases are refractory to treatment. New therapeutic possibilities have emerged with the use of so-called "biologics," a new class of genetically engineered drugs used for inflammatory rheumatic diseases, including rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. In the present review, summarized are the most recent data on the efficacy and safety of biologics in the treatment of vasculitis syndromes that cannot be treated with standard therapy. © 2012 Paroli, publisher and licensee Dove Medical Press Ltd.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know